Pull to refresh
Logo
Daily Brief
Following Why Ranks Sign Up
William Schief

William Schief

Professor, Scripps Research; Executive Director, IAVI Neutralizing Antibody Center

Appears in 1 story

Notable Quotes

"The germline-targeting strategy aims to stimulate the small number of germline B cells capable of maturing into cells that make broadly neutralizing antibodies."

Stories

The 40-year quest for an HIV vaccine enters a new phase

New Capabilities

Lead designer of germline-targeting immunogens being tested in G004

In 1984, the U.S. Health Secretary predicted an HIV vaccine within two years. After four decades and dozens of failed trials, IAVI is dosing participants in South Africa with a vaccine that trains the immune system from the ground up rather than simply presenting viral proteins.

Updated May 22